NPI: 1902865389 · CORBIN, KY 40701 · Occupational Medicine Clinic/Center · NPI assigned 03/22/2006
Authorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | CARRICO, RICHARD (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: CARRICO, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 335,917 | $16.59M |
| 2019 | 320,024 | $16.47M |
| 2020 | 323,465 | $15.74M |
| 2021 | 394,821 | $18.72M |
| 2022 | 388,649 | $17.80M |
| 2023 | 395,002 | $18.90M |
| 2024 | 331,151 | $17.28M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 74,797 | 65,204 | $10.63M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 46,203 | 38,769 | $10.19M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 24,318 | 9,229 | $7.72M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 19,006 | 17,212 | $7.20M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 15,837 | 14,771 | $4.85M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 12,600 | 11,025 | $4.40M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15,011 | 11,276 | $4.30M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 12,558 | 11,022 | $3.73M |
| 93017 | 10,734 | 10,032 | $2.76M | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 33,852 | 14,615 | $2.52M |
| 70450 | Computed tomography, head or brain; without contrast material | 14,816 | 12,113 | $2.40M |
| 47562 | 1,929 | 1,391 | $2.10M | |
| G0378 | Hospital observation service, per hour | 4,115 | 3,217 | $1.62M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 21,795 | 18,375 | $1.50M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5,969 | 2,294 | $1.46M |
| 80053 | Comprehensive metabolic panel | 183,546 | 107,944 | $1.37M |
| 96375 | Therapeutic injection; each additional sequential IV push | 29,412 | 21,895 | $1.18M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 22,709 | 17,100 | $1.14M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 36,997 | 29,769 | $1.03M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,499 | 2,441 | $945K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 34,491 | 18,017 | $943K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 52,683 | 25,121 | $929K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 4,515 | 3,873 | $920K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 6,828 | 6,234 | $890K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,336 | 8,424 | $883K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 123,555 | 100,344 | $843K |
| J0875 | Injection, dalbavancin, 5 mg | 488 | 401 | $806K |
| 59025 | Fetal non-stress test | 8,869 | 5,123 | $796K |
| 74178 | 1,595 | 1,229 | $796K | |
| J2785 | Injection, regadenoson, 0.1 mg | 5,020 | 4,699 | $780K |
| 71045 | Radiologic examination, chest; single view | 29,583 | 24,533 | $778K |
| 72125 | Computed tomography, cervical spine; without contrast material | 4,583 | 3,960 | $737K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 11,922 | 10,522 | $735K |
| 36415 | Collection of venous blood by venipuncture | 187,473 | 93,477 | $716K |
| 96361 | Intravenous infusion, hydration; each additional hour | 14,475 | 10,297 | $702K |
| 72110 | 5,411 | 4,770 | $702K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 3,113 | 2,886 | $699K |
| 74018 | 10,937 | 9,499 | $661K | |
| 72131 | 3,834 | 3,369 | $648K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 4,125 | 2,729 | $624K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8,138 | 7,934 | $618K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 7,424 | 6,868 | $587K |
| 71250 | 5,441 | 4,467 | $573K | |
| 71046 | Radiologic examination, chest; 2 views | 18,518 | 16,260 | $526K |
| 93971 | 3,378 | 3,074 | $518K | |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 3,734 | 532 | $509K |
| 80050 | General health panel | 14,348 | 13,382 | $497K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 5,889 | 5,404 | $473K |
| 96367 | 6,754 | 3,050 | $452K | |
| 0099U | 1,904 | 1,541 | $449K | |
| 73630 | 5,574 | 5,000 | $449K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,403 | 4,417 | $445K |
| 73562 | 5,669 | 5,001 | $431K | |
| 73030 | 6,466 | 5,285 | $422K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,579 | 1,016 | $410K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,919 | 1,698 | $407K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,134 | 951 | $405K |
| J9271 | Injection, pembrolizumab, 1 mg | 86 | 38 | $402K |
| 73610 | 5,259 | 4,601 | $401K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 373 | 369 | $371K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,655 | 2,902 | $366K |
| 70486 | 1,899 | 1,770 | $365K | |
| 93880 | 2,715 | 2,467 | $364K | |
| 72050 | 3,414 | 2,680 | $349K | |
| 73130 | 4,441 | 3,832 | $347K | |
| 84484 | 35,061 | 21,133 | $342K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,337 | 1,014 | $330K |
| 72128 | 2,159 | 1,882 | $327K | |
| S9480 | Intensive outpatient psychiatric services, per diem | 2,421 | 289 | $326K |
| 76775 | 2,686 | 2,212 | $324K | |
| 83880 | 10,775 | 9,215 | $321K | |
| 73110 | 3,871 | 3,286 | $315K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5,846 | 1,785 | $309K |
| 72141 | 1,407 | 1,209 | $306K | |
| 80061 | Lipid panel | 25,075 | 21,747 | $304K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12,322 | 11,393 | $300K |
| 93970 | 1,581 | 1,434 | $299K | |
| 84443 | Thyroid stimulating hormone (TSH) | 20,626 | 18,989 | $291K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,149 | 1,035 | $290K |
| 76642 | 3,078 | 2,912 | $276K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 9,529 | 8,805 | $264K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 643 | 485 | $260K |
| 96376 | 6,689 | 4,834 | $256K | |
| 76536 | 3,154 | 2,895 | $253K | |
| 58571 | 268 | 104 | $250K | |
| 82805 | 5,882 | 4,376 | $247K | |
| 77066 | Tomosynthesis, mammo | 3,578 | 2,907 | $233K |
| 87040 | 26,903 | 13,483 | $219K | |
| 50590 | 276 | 173 | $214K | |
| 73564 | 1,774 | 1,562 | $209K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 25,683 | 19,212 | $208K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 1,084 | 134 | $206K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 690 | 420 | $199K |
| 74022 | 1,897 | 1,806 | $195K | |
| 87507 | 740 | 676 | $193K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,173 | 1,246 | $191K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 379 | 345 | $183K |
| 72072 | 2,080 | 1,810 | $182K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 12,753 | 12,108 | $172K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,276 | 2,127 | $171K |
| 80074 | 4,414 | 3,766 | $171K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 600 | 556 | $169K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,148 | 6,427 | $168K |
| 78227 | 531 | 411 | $168K | |
| 10060 | 596 | 549 | $167K | |
| 83735 | 26,281 | 21,857 | $163K | |
| 82607 | 13,077 | 11,167 | $159K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 22,000 | 19,271 | $153K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 23,021 | 17,285 | $151K |
| 83605 | 17,665 | 13,856 | $147K | |
| 0097U | 617 | 501 | $147K | |
| 93225 | 1,977 | 1,667 | $147K | |
| 94060 | 2,075 | 1,518 | $143K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 17,547 | 16,537 | $142K |
| 73090 | 2,050 | 1,754 | $142K | |
| 93226 | 1,118 | 1,052 | $139K | |
| 73502 | 2,949 | 2,373 | $137K | |
| 83690 | 24,507 | 21,871 | $137K | |
| 73080 | 2,013 | 1,742 | $136K | |
| 78226 | 520 | 401 | $134K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 22,376 | 14,608 | $134K |
| 96368 | 1,561 | 985 | $132K | |
| 86140 | 34,612 | 29,946 | $130K | |
| 77065 | Tomosynthesis, mammo | 2,423 | 1,939 | $130K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,438 | 810 | $128K |
| 82077 | 9,149 | 7,670 | $128K | |
| 72100 | 1,953 | 1,674 | $127K | |
| 73590 | 1,991 | 1,713 | $125K | |
| 74240 | 586 | 550 | $125K | |
| 73221 | 527 | 478 | $123K | |
| 76830 | Ultrasound, transvaginal | 1,442 | 1,347 | $119K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,513 | 1,415 | $118K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9,801 | 6,165 | $117K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,015 | 1,764 | $117K |
| 76870 | 1,501 | 1,394 | $116K | |
| 97602 | 3,612 | 1,750 | $116K | |
| 77080 | 3,481 | 2,431 | $115K | |
| 84439 | 13,970 | 13,002 | $113K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 787 | 554 | $107K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 560 | 533 | $107K |
| 81001 | 39,863 | 32,935 | $107K | |
| 87522 | Neg quan hep c or qual rna | 2,778 | 2,505 | $101K |
| 84112 | 1,144 | 994 | $99K | |
| 80306 | 6,655 | 5,848 | $99K | |
| J7050 | Infusion, normal saline solution, 250 cc | 3,276 | 1,088 | $99K |
| 81025 | 19,979 | 17,900 | $98K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 1,860 | 1,731 | $97K |
| 82728 | 9,405 | 7,350 | $97K | |
| 72040 | 1,154 | 947 | $95K | |
| 87081 | 13,110 | 12,264 | $91K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 157 | 108 | $90K |
| 12001 | 1,179 | 1,083 | $90K | |
| C1769 | Guide wire | 1,087 | 954 | $90K |
| 70491 | 542 | 365 | $88K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 329 | 265 | $88K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,802 | 2,600 | $86K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 447 | 364 | $83K |
| 87902 | 406 | 374 | $83K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,747 | 2,589 | $82K |
| 87150 | 364 | 331 | $79K | |
| 0002A | 3,750 | 3,511 | $77K | |
| 96415 | 493 | 328 | $77K | |
| 36600 | 5,027 | 4,122 | $75K | |
| 84466 | 6,615 | 6,121 | $75K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,216 | 836 | $74K |
| 85027 | 12,958 | 11,498 | $74K | |
| 84703 | 10,619 | 9,795 | $72K | |
| 71271 | 1,424 | 1,288 | $72K | |
| 0001A | 4,028 | 3,714 | $68K | |
| 58661 | 68 | 61 | $68K | |
| 84403 | 2,884 | 2,747 | $66K | |
| 70498 | 431 | 365 | $66K | |
| C1889 | Implantable/insertable device, not otherwise classified | 991 | 739 | $66K |
| 84145 | 3,484 | 3,094 | $65K | |
| 84702 | 4,517 | 3,662 | $65K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,112 | 316 | $65K |
| J2704 | Injection, propofol, 10 mg | 18,762 | 15,474 | $64K |
| 85379 | 7,185 | 6,591 | $63K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 1,274 | 1,207 | $63K |
| 85610 | 19,889 | 14,535 | $63K | |
| 86003 | 935 | 885 | $62K | |
| J2505 | Injection, pegfilgrastim, 6 mg | 16 | 12 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,615 | 1,418 | $60K |
| 86850 | 6,790 | 5,926 | $60K | |
| 94726 | 2,213 | 1,569 | $59K | |
| 81003 | 27,386 | 24,573 | $59K | |
| 70496 | 356 | 287 | $57K | |
| 71101 | 820 | 616 | $56K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 926 | 838 | $56K |
| 82375 | 5,624 | 4,170 | $55K | |
| 90715 | 2,151 | 2,010 | $55K | |
| 87186 | 7,081 | 5,879 | $54K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 672 | 605 | $54K |
| 84153 | 4,574 | 3,887 | $53K | |
| 85730 | 9,548 | 8,278 | $52K | |
| 95819 | 195 | 151 | $51K | |
| 94729 | 1,442 | 1,388 | $47K | |
| 96417 | 391 | 237 | $47K | |
| 83540 | 7,895 | 7,233 | $46K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,121 | 663 | $46K |
| 93925 | 453 | 408 | $46K | |
| 77336 | 482 | 89 | $45K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 11,078 | 9,298 | $44K |
| 64488 | 101 | 84 | $44K | |
| 75574 | 174 | 147 | $43K | |
| 12002 | 470 | 440 | $42K | |
| 82746 | 3,395 | 3,162 | $42K | |
| 82150 | 7,451 | 6,730 | $42K | |
| 82670 | 2,442 | 1,706 | $41K | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 3,822 | 2,482 | $40K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,694 | 1,608 | $39K |
| J7030 | Infusion, normal saline solution , 1000 cc | 9,114 | 4,409 | $39K |
| 76819 | Fetal biophysical profile; without non-stress testing | 507 | 409 | $37K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 20,788 | 13,842 | $36K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 1,774 | 438 | $35K |
| 82550 | 5,946 | 4,671 | $35K | |
| 0100U | 71 | 69 | $35K | |
| 87077 | 4,861 | 3,866 | $33K | |
| 85652 | 15,032 | 13,447 | $33K | |
| 82962 | 10,288 | 5,540 | $31K | |
| 74019 | 483 | 430 | $31K | |
| 74220 | 278 | 253 | $31K | |
| J2805 | Injection, sincalide, 5 micrograms | 281 | 267 | $31K |
| 73060 | 489 | 413 | $30K | |
| 87070 | 5,259 | 3,556 | $30K | |
| 86803 | 2,309 | 2,209 | $30K | |
| 83050 | 5,343 | 4,125 | $30K | |
| 81596 | 493 | 452 | $29K | |
| 76801 | 425 | 391 | $29K | |
| 73523 | 223 | 158 | $28K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 11,157 | 8,974 | $28K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,407 | 2,157 | $27K |
| 87807 | 1,808 | 1,702 | $26K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 22,469 | 19,264 | $26K |
| 82105 | 1,408 | 1,280 | $26K | |
| 87147 | 3,384 | 2,296 | $26K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 480 | 409 | $25K |
| 73560 | 333 | 302 | $24K | |
| 80143 | 1,472 | 1,330 | $24K | |
| 86038 | 2,243 | 2,087 | $24K | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 5,687 | 3,298 | $23K |
| 19081 | 32 | 27 | $23K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 5,548 | 4,575 | $23K |
| 86901 | 6,865 | 6,018 | $23K | |
| 86900 | 6,998 | 6,036 | $23K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 107 | 103 | $23K |
| 82043 | 4,388 | 4,012 | $23K | |
| 92526 | 459 | 154 | $23K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,656 | 939 | $22K |
| 73552 | 403 | 345 | $22K | |
| 87493 | 827 | 741 | $22K | |
| 73700 | 85 | 75 | $22K | |
| 76882 | 240 | 225 | $22K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 4,825 | 4,134 | $21K |
| 86677 | 762 | 730 | $21K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 7,938 | 5,771 | $21K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 31,460 | 25,699 | $20K |
| 94727 | 496 | 474 | $20K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 868 | 789 | $20K |
| 84481 | 1,350 | 1,253 | $19K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 4,378 | 3,960 | $19K |
| 82784 | 2,020 | 1,787 | $19K | |
| 80179 | 1,404 | 1,286 | $18K | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 1,702 | 1,280 | $18K |
| 83615 | 3,327 | 2,813 | $17K | |
| 12011 | 189 | 173 | $17K | |
| 83516 | 1,031 | 631 | $17K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 3,654 | 3,167 | $17K |
| 78264 | 55 | 43 | $17K | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 9,095 | 8,428 | $16K |
| 36430 | 77 | 50 | $16K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 13,335 | 10,935 | $16K |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,401 | 1,559 | $16K |
| 73140 | 245 | 223 | $16K | |
| 83655 | 1,327 | 1,305 | $16K | |
| 82948 | 3,316 | 1,823 | $16K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 7,978 | 6,164 | $15K |
| 72146 | 61 | 56 | $15K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,034 | 2,538 | $15K |
| 87205 | 3,821 | 3,277 | $15K | |
| 84550 | 3,507 | 2,976 | $15K | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 253 | 167 | $14K |
| 72081 | 80 | 80 | $14K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 314 | 275 | $14K |
| 84100 | 3,491 | 2,586 | $14K | |
| J1756 | Injection, iron sucrose, 1 mg | 231 | 84 | $13K |
| 86706 | 1,450 | 1,321 | $13K | |
| 82570 | 2,914 | 2,612 | $13K | |
| 82553 | 1,235 | 776 | $12K | |
| 92609 | 167 | 67 | $12K | |
| 83993 | 648 | 619 | $11K | |
| 86364 | 1,027 | 988 | $11K | |
| 97016 | 1,002 | 134 | $11K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 2,649 | 1,793 | $11K |
| 93308 | 78 | 68 | $11K | |
| 84134 | 885 | 778 | $11K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 600 | 465 | $11K |
| 82785 | 587 | 534 | $11K | |
| 86704 | 1,044 | 957 | $11K | |
| 97035 | 385 | 136 | $10K | |
| 92523 | 126 | 119 | $10K | |
| 93798 | 726 | 103 | $10K | |
| 97162 | 227 | 214 | $10K | |
| 93325 | 110 | 101 | $10K | |
| 86708 | 951 | 866 | $10K | |
| 82140 | 971 | 708 | $9K | |
| 77300 | 51 | 14 | $9K | |
| J1453 | Injection, fosaprepitant, 1 mg | 94 | 65 | $9K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,512 | 1,066 | $9K |
| 82248 | 1,917 | 1,526 | $9K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 14,471 | 12,581 | $9K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 110 | 51 | $9K |
| 93320 | 68 | 51 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 382 | 366 | $9K |
| A4648 | Tissue marker, implantable, any type, each | 96 | 92 | $8K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,583 | 1,340 | $8K |
| 36416 | 4,509 | 1,482 | $8K | |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 995 | 830 | $8K |
| 86308 | 1,712 | 1,643 | $8K | |
| 76506 | 95 | 94 | $8K | |
| 93356 | 412 | 372 | $8K | |
| 84156 | 2,313 | 2,080 | $8K | |
| 84402 | 384 | 352 | $8K | |
| Q9968 | Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg | 117 | 73 | $8K |
| 86231 | 796 | 771 | $8K | |
| 87899 | 441 | 299 | $8K | |
| 87340 | 953 | 881 | $8K | |
| 87088 | 1,101 | 1,028 | $8K | |
| 84436 | 1,252 | 1,150 | $7K | |
| 83550 | 795 | 730 | $7K | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,956 | 1,458 | $7K |
| 93923 | 117 | 100 | $7K | |
| 29125 | 111 | 95 | $7K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 1,302 | 540 | $7K |
| 86376 | 553 | 527 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 90 | 38 | $7K |
| 99195 | 213 | 176 | $7K | |
| 86431 | 1,379 | 1,302 | $7K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 2,387 | 2,207 | $7K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 412 | 376 | $7K |
| 87631 | 42 | 40 | $7K | |
| 93922 | 121 | 102 | $7K | |
| 82247 | 1,390 | 1,020 | $7K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,350 | 742 | $6K |
| 82977 | 966 | 863 | $6K | |
| J3490 | Unclassified drugs | 91 | 84 | $6K |
| 97163 | 167 | 149 | $6K | |
| 36591 | 460 | 153 | $6K | |
| 83010 | 563 | 462 | $6K | |
| 83874 | 473 | 271 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 208 | 177 | $6K |
| 87046 | 442 | 289 | $6K | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 2,384 | 2,036 | $6K |
| 96411 | 50 | 28 | $6K | |
| 80076 | 726 | 632 | $6K | |
| 73120 | 87 | 80 | $6K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 14 | 12 | $6K |
| 72220 | 100 | 69 | $6K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 71 | 69 | $5K |
| 87209 | 274 | 244 | $5K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 30 | 13 | $5K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 4,137 | 2,220 | $5K |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 43 | 38 | $5K |
| 74246 | 55 | 50 | $5K | |
| C1781 | Mesh (implantable) | 15 | 12 | $5K |
| 72082 | 13 | 13 | $5K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 45 | 42 | $4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,687 | 2,812 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,459 | 1,213 | $4K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 28 | 28 | $4K |
| 91035 | 16 | 14 | $4K | |
| 0042T | 15 | 12 | $4K | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 2,085 | 1,732 | $4K |
| 94010 | 93 | 71 | $4K | |
| 84146 | 217 | 204 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 2,656 | 2,104 | $3K |
| 43248 | 15 | 14 | $3K | |
| 51702 | 45 | 30 | $3K | |
| 78306 | 28 | 13 | $3K | |
| 83883 | 213 | 158 | $3K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 17 | 14 | $3K |
| 94761 | 429 | 217 | $3K | |
| 87581 | 115 | 111 | $3K | |
| 87486 | 115 | 111 | $3K | |
| 74241 | 12 | 12 | $3K | |
| 87045 | 355 | 297 | $3K | |
| 82378 | 147 | 130 | $3K | |
| 0004A | 216 | 202 | $3K | |
| 87177 | 287 | 250 | $3K | |
| 82172 | 140 | 121 | $3K | |
| 82525 | 263 | 132 | $3K | |
| 82009 | 707 | 607 | $2K | |
| 86618 | 170 | 145 | $2K | |
| 83525 | 237 | 229 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 369 | 321 | $2K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,534 | 1,823 | $2K |
| J3411 | Injection, thiamine hcl, 100 mg | 503 | 418 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 460 | 373 | $2K |
| 96523 | 312 | 209 | $2K | |
| 76885 | 24 | 24 | $2K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 630 | 566 | $2K |
| 72170 | 46 | 38 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 136 | 81 | $2K |
| 83970 | 67 | 65 | $2K | |
| 86258 | 125 | 124 | $2K | |
| 80202 | 138 | 61 | $2K | |
| C1726 | Catheter, balloon dilatation, non-vascular | 13 | 12 | $2K |
| 83001 | 128 | 121 | $2K | |
| 81050 | 547 | 388 | $2K | |
| 86008 | 219 | 213 | $2K | |
| 86800 | 134 | 124 | $2K | |
| 86757 | 31 | 28 | $2K | |
| 84132 | 505 | 344 | $2K | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 416 | 293 | $2K |
| 82270 | 404 | 365 | $2K | |
| 83002 | 112 | 103 | $2K | |
| 82652 | 40 | 37 | $2K | |
| 94664 | 82 | 55 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 389 | 327 | $2K |
| 73000 | 18 | 16 | $1K | |
| 84479 | 268 | 251 | $1K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 664 | 607 | $1K |
| 80164 | 162 | 135 | $1K | |
| 82653 | 27 | 27 | $1K | |
| 85014 | 310 | 177 | $1K | |
| 81206 | 15 | 14 | $1K | |
| 73070 | 13 | 12 | $1K | |
| J1790 | Injection, droperidol, up to 5 mg | 322 | 274 | $1K |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 261 | 225 | $1K |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 504 | 466 | $1K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 92 | 77 | $1K |
| 82103 | 87 | 86 | $1K | |
| 83921 | 63 | 62 | $1K | |
| 81207 | 15 | 14 | $1K | |
| 83631 | 56 | 54 | $1K | |
| 73503 | 14 | 13 | $1K | |
| 93246 | 27 | 27 | $992.63 | |
| 84630 | 77 | 75 | $977.28 | |
| 86592 | 283 | 258 | $974.79 | |
| 85045 | 256 | 209 | $934.79 | |
| 86666 | 28 | 27 | $869.92 | |
| 83520 | 40 | 25 | $862.72 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 984 | 816 | $850.63 |
| 86255 | 56 | 55 | $821.65 | |
| 85049 | 61 | 26 | $796.38 | |
| 93242 | 24 | 24 | $727.68 | |
| 74230 | 23 | 12 | $714.04 | |
| 0003A | 59 | 56 | $679.20 | |
| 82533 | 44 | 41 | $657.72 | |
| 86200 | 58 | 55 | $654.60 | |
| 82272 | 261 | 195 | $648.99 | |
| 86769 | 17 | 13 | $639.26 | |
| 97535 | Self-care/home management training, each 15 minutes | 43 | 13 | $628.22 |
| 94760 | 83 | 79 | $588.10 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 91 | 78 | $579.60 |
| 84460 | 118 | 96 | $570.44 | |
| 84144 | 32 | 25 | $557.09 | |
| 85007 | 191 | 174 | $525.52 | |
| J3480 | Injection, potassium chloride, per 2 meq | 57 | 28 | $515.90 |
| 97139 | 156 | 42 | $493.57 | |
| 87484 | 23 | 16 | $458.12 | |
| 83630 | 28 | 25 | $450.08 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 43 | 37 | $445.86 |
| 82104 | 31 | 31 | $433.80 | |
| 84478 | 95 | 59 | $431.43 | |
| 87468 | 23 | 16 | $382.71 | |
| 86753 | 17 | 16 | $327.75 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 15 | 14 | $324.70 |
| 86015 | 25 | 25 | $289.20 | |
| J1940 | Injection, furosemide, up to 20 mg | 128 | 94 | $289.04 |
| 87210 | 57 | 56 | $277.87 | |
| 82390 | 24 | 24 | $277.26 | |
| 84480 | 35 | 27 | $273.48 | |
| 86381 | 12 | 12 | $249.41 | |
| 86668 | 14 | 14 | $237.38 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 110 | 98 | $236.49 |
| 87220 | 45 | 44 | $229.13 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 127 | 105 | $208.12 |
| 85018 | 103 | 64 | $192.95 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 301 | 273 | $191.29 |
| 90686 | 17 | 14 | $183.97 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 13 | 12 | $173.20 |
| Q3014 | Telehealth originating site facility fee | 33 | 26 | $163.76 |
| G0008 | Administration of influenza virus vaccine | 17 | 14 | $151.91 |
| 76999 | 32 | 24 | $146.22 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 120 | 94 | $146.20 |
| 86141 | 12 | 12 | $142.45 | |
| 82330 | 13 | 12 | $136.80 | |
| 82465 | 30 | 30 | $117.54 | |
| J1953 | Injection, levetiracetam, 10 mg | 12 | 12 | $103.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 158 | 132 | $99.26 |
| 85384 | 12 | 12 | $98.17 | |
| 80178 | 14 | 12 | $86.98 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 14 | 12 | $81.41 |
| 85651 | 18 | 16 | $57.58 | |
| 82947 | 12 | 12 | $12.26 | |
| 99499 | 106 | 97 | $0.00 |